GINNA MILENA ORTIZ OLIVERA

Compassionate gynecologist with 10+ years of experience in the reproductive field, including 12 years in hospital and private practice settings. Expertise in patient care and implementing reproductive technology, with a track record of successfully completing over 1000 cycles of IVF and egg donation. Possesses extensive knowledge of medication administration and meticulous medical record-keeping. Dedicated and passionate professional with strong organizational skills, committed to supporting the team in achieving company goals.

• Dubai Health Authority Eligibility Letter (UAE)
• Mexican Council Of Obstetrics and Gynecology (Mexico)
• Colombian Ministry of Health License (Colombia)

• Addition of multi-level technologies to evaluate eggs and embryos and improve endometrial quality applied for in vitro fertilization to achieve pregnancy: a case study. Dec, 2024
• Improvement of endometrial thickness and in vitro fertilization outcomes in patients with Ackerman's refractory endometrium using autologous mesenchymal stem cells from the stromal vascular fraction. Am J Transl Res. 2024 Aug.
• Adding a ketogenic dietary intervention to IVF treatment in patients with polycystic ovary syndrome improves implantation and pregnancy. Reproductive Toxicology · Feb. 2023
• Surgical and nutritional interventions for endometrial receptivity: A case report and review of literature. World Journal of clinical cases · 2022
• Early Multifetal Pregnancy Reduction Outcomes: Non- Chemical-Based Method Yield Improved Pregnancy Rates and Minimized Risks. World Journal of Gynecology & Women's Health · 23 ago. 2021.
• Successful management of cervical ectopic pregnancy with embryo reduction: report of 3 cases. Journal of Surgical Case Reports. May. 2021.
• Initial ovarian sensitivity index predicts embryo quality and pregnancy potential in the first days of controlled ovarian stimulation. Journal of ovarian research · Ag. 2020
• Prediction of severe ovarian hyperstimulation syndrome in women undergoing in vitro fertilisation using estradiol levels, collected ova, and number of follicles. Journal Of International Medical Research · Ag. 2020
• Assessment of Prostaglandin-Endoperoxide synthase 2 and Versican gene expression profile from the cumulus cells: association with better in vitro fertilization outcomes. Journal of Ovarian Research · Oct. 2018
• Versican and prostaglandin-endoperoxide synthase 2 (PTGS2) gene expression in cumulus cells as a complement of preimplantation genetic testing: better outcomes for In Vitro Fertilization pregnancy. Poster in ASRM congress 2017
• "Usó de etanercept en pacientes con fallo de implantación y endometriosis severa, reporte de un caso" Poster 54 congreso mexicano de medicina de la reproducción · 20 jul. 2017
• ¿Existe relación entre el nivel seríco de progesterona en día de disparo y los resultados de FIV en ciclos de antagonista de GnRH? Congreso de la AMMR · Sept. 2016
• Anthiphospholipid antibodies prevalence in reproductive failure and inmunological related diseases. 11 taller general Red Lara, Panama, 2013 ·
• Is reliable the new semen analysis of the WHO laboratory manual for the diagnosis of the male factor in an infertile population?JBRA - Assisted Reproduction. V. 17 | nº2 | Mar-Apr / 2013
• Validación de la hormona antimulleriana como predictor de reserva ovárica en una poblacion Colombiana. Revista Controversias, No8, 2013.
• Is age a determining factor for the election of the protocol in luteal phase support in a in vitro fertilization program? Poster. 15 World Congress of gynecological endocrinology, florencia, Italia · 15 mar. 2012
• Immunotherapy for patients with recurrent pregnancy loss: a myth of past or an option for the future. Poster. 15 worldwide Endocrinology Meeting. Florence, Italy. 15 mar. 2012
• Do Mullerian anormalies affect embryo implantation? Eshre · 10 sept. 2011
• The Role of LH in Ovarian Stimulation. Curr Pharm Biotechnol. · 9 jun. 2011